文献速递消化道肿瘤与早癌食管胃疾病与幽门螺杆菌

成纤维细胞来源SPON2促进化生胃上皮细胞向异型增生转变

Fibroblast-Derived Spondin-2 Promotes Dysplastic Transition in Metaplastic Gastric Epithelial Cells.
PubMed 文献 · Gastroenterology · 2026-08-25

本研究通过单细胞RNA测序和蛋白质组学分析患者来源成纤维细胞,发现SPON2是化生及癌相关成纤维细胞中最上调且选择性分泌的蛋白。空间转录组显示PDGFRA/SPON2共表达成纤维细胞毗邻人胃组织化生腺体。敲低SPON2可消除共培养中SPEM谱系胃类器官的异型增生诱导,而重组SPON2处理化生胃类器官可下调化生标志物并上调异型增生相关蛋白,且停药后细胞恢复化生标志物。结论:成纤维细胞来源SPON2是驱动胃上皮化生向异型增生转变的关键分泌因子。

要点

  • SPON2是化生及癌相关成纤维细胞中最上调且选择性分泌的蛋白
  • SPON2+成纤维细胞定位于人胃组织化生腺体邻近区域
  • 敲低SPON2消除共培养中异型增生诱导,重组SPON2可逆性诱导异型增生标志物

核心结论

  • 成纤维细胞来源的SPON2是驱动胃上皮化生向异型增生转变的有效分泌因子,是首个可促进癌前进展的成纤维细胞来源分泌因子。

研究设计与样本

  • 研究采用患者来源成纤维细胞进行单细胞RNA测序和条件培养基蛋白质组学分析,并利用空间转录组学评估SPON2+成纤维细胞在人胃组织中的定位。
  • 在体外共培养体系中,对癌来源成纤维细胞进行SPON2敲低并与SPEM谱系胃类器官共培养,同时对化生胃类器官应用重组SPON2处理。

主要发现

  • 单细胞RNA测序和蛋白质组学显示,与正常成纤维细胞相比,SPON2是化生和癌来源成纤维细胞中最上调且选择性分泌的蛋白。
  • 空间转录组学显示PDGFRA/SPON2共表达成纤维细胞定位于人胃组织化生腺体邻近区域。
  • 敲低癌来源成纤维细胞中的SPON2可消除共培养SPEM谱系胃类器官中异型增生的诱导,同时保留化生标志物。
  • 重组SPON2处理化生胃类器官可促进化生标志物下调和异型增生相关蛋白上调;停止SPON2处理后,胃类器官细胞失去异型增生标志物并恢复化生标志物。

临床怎么用

  • SPON2可作为胃黏膜化生向异型增生进展的潜在生物标志物和干预靶点,但尚需临床转化验证。

局限性

  • 研究主要基于体外类器官共培养模型和人组织空间转录组学,尚缺乏体内功能实验和临床队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Fibroblasts are increasingly recognized as active drivers of early gastric carcinogenesis, yet the specific fibroblast-derived factors that promote the transition from metaplasia to dysplasia remain unknown. We have recently found that coculture of metaplasia or cancer-derived fibroblasts with gastroids dominated by spasmolytic polypeptide-expressing metaplasia (SPEM) lineages leads to a decrease of metaplastic markers and a concomitant up-regulation of dysplasia markers. We have now identified the matricellular protein Spondin-2 (SPON2) as a key fibroblast-secreted mediator of this transition. METHODS: Single-cell RNA-sequencing of patient-derived fibroblast populations and proteomic profiling of conditioned media were used to identify fibroblast-secreted factors. Spatial transcriptomics was used to evaluate localization of SPON2+ fibroblasts in human gastric tissue. Knockdown of SPON2 in cancer-derived fibroblasts was performed in coculture with SPEM lineage gastroids, and recombinant SPON2 treatment was applied to metaplastic gastroids. RESULTS: Single-cell RNA-sequencing and proteomic profiling revealed SPON2 as the most up-regulated and selectively secreted protein in metaplasia- and cancer-derived fibroblasts compared with normal fibroblasts. Spatial transcriptomics demonstrated PDGFRA/SPON2 coexpressing fibroblasts localized adjacent to metaplastic glands in human gastric tissue. Knockdown of SPON2 in cancer-derived fibroblasts abrogated induction of dysplastic promotion in cocultured SPEM lineage gastroids, while preserving metaplastic markers. Conversely, recombinant SPON2 treatment promoted down-regulation of metaplastic markers and up-regulation of dysplasia-associated proteins in metaplastic gastroids. After cessation of SPON2 treatment, gastroid cells lost their dysplastic markers and regained metaplastic markers. CONCLUSIONS: These findings identify fibroblast-derived SPON2 as a potent secreted factor driving the metaplasia-to-dysplasia transition in gastric epithelium. Therefore, SPON2 represents the first fibroblast-derived secreted factor that can promote preneoplastic progression.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Rhodes JD, Hur S, Zhang C, et al. Fibroblast-Derived Spondin-2 Promotes Dysplastic Transition in Metaplastic Gastric Epithelial Cells. Gastroenterology. 2026. PMID: 42641992. doi:10.1053/j.gastro.2026.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。